FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules
Headline from The Conversation US
The FDA’s new framework for COVID-19 vaccines breaks from established procedure for how the government establishes vaccine guidelines.
The Conversation US's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
U.S. regulators will no longer approve COVID booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
WASHINGTON (AP) — The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else
Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.
Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people under 65 to get immunized.
FDA unveils new policy limiting annual COVID-19 shots to high-risk groups, raising questions about vaccine availability for healthy adults and children
Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.
(CNN) — The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious Covid-19 infection.
The FDA announced in a paper published Tuesday that COVID-19 vaccines will only be available for people over 65 and people with at least one medical condition that puts them at risk for severe COVID. Vaccines must undergo further, rigorous studies before approval for healthy adults and children, reg…
The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical
The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other "high-risk" individuals, while increasing the standard of evidence to approve COVID vaccines for low-risk individuals.
The United States will restrict routine COVID-19 boosters to people over 65 or those at higher risk of serious illness, while requiring new placebo-controlled trials to justify vaccination in healthy individuals under that age, senior officials said Tuesday.
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift away from the current approach of universally green-lighting the shots, and comes just two days before …
WASHINGTON (AP) — Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled
The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at
Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit the approval of updated COVID-19 vaccines to adults over 65 and people who are high risk for severe infections.
Companies that want to market their vaccines to those Americans will need to conduct large, new studies, the Food and Drug Administration said Tuesday.
WASHINGTON (AP) — Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Tru
Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.
